Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets. Lipoprotein(a) binding is independent of an arginyl-glycyl-aspartate tripeptide located in apolipoprotein(a)

« Previous Article | Table of Contents | Next Article »

Arteriosclerosis, Thrombosis, and Vascular Biology. 1994;14:345-352

This Article

	Full Text (PDF)
	Submit a response
	Alert me when this article is cited
	Alert me when eLetters are posted
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Request Permissions

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Malle, E.
	Articles by Sattler, W.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Malle, E.
	Articles by Sattler, W.

ARTICLES

Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets. Lipoprotein(a) binding is independent of an arginyl-glycyl-aspartate tripeptide located in apolipoprotein(a)

E Malle, A Ibovnik, A Stienmetz, GM Kostner and W Sattler
Department of Internal Medicine, Philipps University, Marburg, Germany.

Lipoprotein(a) [Lp(a)] plays an important role in atherosclerosis. The amino acid sequence of apolipoprotein(a) [apo(a)] reveals an arginyl- glycyl-aspartate (RGD) tripeptide that is the consensus sequence for binding of adhesive plasma proteins of the fibrinolytic system, such as fibrinogen and von Willebrand factor, to the platelet membrane glycoprotein IIb-IIIa (GPIIb-IIIa) complex. Therefore, we undertook the present study to further investigate the role of Lp(a) in hemostasis. Binding of 125I-Lp(a) to a single platelet membrane-associated protein (137 +/- 6 kD) comigrating with platelet GPIIb (140 kD) was found to be specific, saturable, and Ca2+ independent. Binding of 125I-Lp(a) to resting human blood platelets was saturable, insensitive to temperature, and independent of the apo(a) isoform (B, S1 through S3). Scatchard analysis revealed a Kd of 7.2 +/- 1.8 x 10(-9) mol/L, with 729 +/- 313 Lp(a) molecules bound per platelet. Monoclonal anti-GPIIb IgG diminished Lp(a) binding by approximately 80%, monoclonal anti- GPIIb-IIIa IgG by 60%, and anti-GPIIIa IgG by just 15%. 125I-Lp(a) binding was competitively inhibited to the same extent by either unlabeled Lp(a) or fibrinogen. Low- and high-density lipoproteins were much weaker competitors. A polyclonal antibody raised against the RGDGQSYRGT sequence of apo(a) was used to verify the presence of an RGD sequence in the different Lp(a) preparations investigated. However, two lines of evidence indicated that the RGD sequence is not the binding domain mediating Lp(a) binding to platelets. First, incubation of platelets with isolated RGD tripeptide did not influence Lp(a) binding.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

G. Marsche, P. G. Furtmuller, C. Obinger, W. Sattler, and E. Malle
Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro
Cardiovasc Res, July 1, 2008; 79(1): 187 - 194.
[Abstract] [Full Text] [PDF]

L. D Tsironis, J. V Mitsios, H. J Milionis, M. Elisaf, and A. D Tselepis
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase
Cardiovasc Res, July 1, 2004; 63(1): 130 - 138.
[Abstract] [Full Text] [PDF]

C. M. Hackeng, M. Huigsloot, M. W. Pladet, H. K. Nieuwenhuis, H. J. M. van Rijn, and J.-W. N. Akkerman
Low-Density Lipoprotein Enhances Platelet Secretion Via Integrin-{alpha}IIb�3�Mediated Signaling
Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 239 - 247.
[Abstract] [Full Text] [PDF]

M. L. Rand, W. Sangrar, M. A. Hancock, D. M. Taylor, S. M. Marcovina, M. A. Packham, and M. L. Koschinsky
Apolipoprotein(a) Enhances Platelet Responses to the Thrombin Receptor�Activating Peptide SFLLRN
Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1393 - 1399.
[Abstract] [Full Text] [PDF]

P. Alaigh, C. J. Hoffman, G. Korlipara, A. Neuroth, J. P. Dervan, W. E. Lawson, and M. B. Hultin
Lipoprotein(a) Level Does Not Predict Restenosis After Percutaneous Transluminal Coronary Angioplasty
Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1281 - 1286.
[Abstract] [Full Text] [PDF]

J. Pedreno, R. Fernandez, C. Cullare, A. Barcelo, M. A. Elorza, and C. de Castellarnau
Platelet Integrin {alpha}IIb�3 (GPIIb-IIIa) Is Not Implicated in the Binding of LDL to Intact Resting Platelets
Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 156 - 163.
[Abstract] [Full Text]

A. Gries, M. Gries, H. Wurm, T. Kenner, M. Ijsseldijk, J. J. Sixma, and G. M. Kostner
Lipoprotein(a) Inhibits Collagen-Induced Aggregation of Thrombocytes
Arterioscler Thromb Vasc Biol, May 1, 1996; 16(5): 648 - 655.
[Abstract] [Full Text]

E. Malle, L. Hazell, R. Stocker, W. Sattler, H. Esterbauer, and G. Waeg
Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal Antibodies
Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 982 - 989.
[Abstract] [Full Text]

E. Malle, A. Ibovnik, H. J. Leis, G. M. Kostner, P. F. J. Verhallen, and W. Sattler
Lysine Modification of LDL or Lipoprotein(a) by 4-Hydroxynonenal or Malondialdehyde Decreases Platelet Serotonin Secretion Without Affecting Platelet Aggregability and Eicosanoid Formation
Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 377 - 384.
[Abstract] [Full Text]

				L. D Tsironis, J. V Mitsios, H. J Milionis, M. Elisaf, and A. D Tselepis Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase Cardiovasc Res, July 1, 2004; 63(1): 130 - 138. [Abstract] [Full Text] [PDF]

				C. M. Hackeng, M. Huigsloot, M. W. Pladet, H. K. Nieuwenhuis, H. J. M. van Rijn, and J.-W. N. Akkerman Low-Density Lipoprotein Enhances Platelet Secretion Via Integrin-{alpha}IIb�3�Mediated Signaling Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 239 - 247. [Abstract] [Full Text] [PDF]

				M. L. Rand, W. Sangrar, M. A. Hancock, D. M. Taylor, S. M. Marcovina, M. A. Packham, and M. L. Koschinsky Apolipoprotein(a) Enhances Platelet Responses to the Thrombin Receptor�Activating Peptide SFLLRN Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1393 - 1399. [Abstract] [Full Text] [PDF]

				P. Alaigh, C. J. Hoffman, G. Korlipara, A. Neuroth, J. P. Dervan, W. E. Lawson, and M. B. Hultin Lipoprotein(a) Level Does Not Predict Restenosis After Percutaneous Transluminal Coronary Angioplasty Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1281 - 1286. [Abstract] [Full Text] [PDF]

				J. Pedreno, R. Fernandez, C. Cullare, A. Barcelo, M. A. Elorza, and C. de Castellarnau Platelet Integrin {alpha}IIb�3 (GPIIb-IIIa) Is Not Implicated in the Binding of LDL to Intact Resting Platelets Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 156 - 163. [Abstract] [Full Text]

				A. Gries, M. Gries, H. Wurm, T. Kenner, M. Ijsseldijk, J. J. Sixma, and G. M. Kostner Lipoprotein(a) Inhibits Collagen-Induced Aggregation of Thrombocytes Arterioscler Thromb Vasc Biol, May 1, 1996; 16(5): 648 - 655. [Abstract] [Full Text]

				E. Malle, L. Hazell, R. Stocker, W. Sattler, H. Esterbauer, and G. Waeg Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal Antibodies Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 982 - 989. [Abstract] [Full Text]

				E. Malle, A. Ibovnik, H. J. Leis, G. M. Kostner, P. F. J. Verhallen, and W. Sattler Lysine Modification of LDL or Lipoprotein(a) by 4-Hydroxynonenal or Malondialdehyde Decreases Platelet Serotonin Secretion Without Affecting Platelet Aggregability and Eicosanoid Formation Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 377 - 384. [Abstract] [Full Text]